| |
| |
|
| Insider
Information: |
Bitterman Kevin |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
8,084,902 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$42,541,856 |
|
|
| Total
Shares |
8,084,902 |
|
|
| Total
Value |
$42,541,856 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-7.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -367.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genocea Biosciences, Inc. |
GNCA |
Director |
2014-02-10 |
0 |
2014-02-10 |
2,128,678 |
Premium* |
|
|
Editas Medicine, Inc. |
EDIT |
Director |
2016-02-08 |
0 |
2017-05-22 |
2,797,144 |
Premium* |
|
|
Akero Therapeutics, Inc. |
AKRO |
Director |
2019-06-24 |
0 |
2021-06-01 |
2,232,251 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
|
|
0 |
2024-03-05 |
926,829 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IRON |
Disc Medicine, Inc |
|
– • – |
2024-03-05 |
4 |
S |
$73.50 |
$1,922,540 |
I/I |
(26,157) |
677,503 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
Director |
– • – |
2024-01-23 |
4 |
S |
$67.65 |
$6,934,125 |
I/I |
(102,500) |
198,326 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
Director |
– • – |
2024-01-10 |
4 |
S |
$64.00 |
$1,280,000 |
I/I |
(20,000) |
786,160 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
Director |
– • – |
2023-12-14 |
4 |
S |
$58.27 |
$1,197,567 |
I/I |
(20,549) |
806,160 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
Director |
– • – |
2023-12-13 |
4 |
S |
$59.99 |
$212,865 |
I/I |
(3,548) |
826,709 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
Director |
– • – |
2023-12-12 |
4 |
S |
$59.87 |
$3,263,328 |
I/I |
(51,967) |
830,257 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
Director |
– • – |
2023-08-15 |
4 |
S |
$52.40 |
$3,821,584 |
I/I |
(72,931) |
882,224 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
Director |
– • – |
2022-12-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,173,482 |
|
% |
|
| IRON |
Disc Medicine, Inc |
Director |
– • – |
2022-12-29 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
51,000 |
|
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Director |
– • – |
2021-06-01 |
4 |
AS |
$26.28 |
$459,611 |
I/I |
(17,489) |
0 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Director |
– • – |
2020-10-09 |
4 |
S |
$28.93 |
$376,090 |
I/I |
(13,000) |
11,780 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Director |
– • – |
2019-06-24 |
4 |
B |
$16.00 |
$4,320,000 |
I/I |
270,000 |
505,099 |
2.1 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Director |
– • – |
2019-06-24 |
4 |
A |
$0.00 |
$0 |
I/I |
3,704,858 |
235,099 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • – |
2017-05-22 |
4 |
S |
$17.00 |
$17,000,000 |
I/I |
(1,000,000) |
2,797,144 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • • |
2016-12-07 |
4 |
S |
$15.82 |
$1,186,500 |
I/I |
(75,000) |
3,797,144 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • • |
2016-12-06 |
4 |
S |
$15.87 |
$793,500 |
I/I |
(50,000) |
3,872,144 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • • |
2016-12-05 |
4 |
S |
$15.74 |
$1,259,200 |
I/I |
(80,000) |
3,922,144 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • • |
2016-11-23 |
4 |
S |
$15.71 |
$337,451 |
I/I |
(21,480) |
4,002,144 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • • |
2016-11-22 |
4 |
S |
$15.77 |
$202,156 |
I/I |
(12,819) |
4,023,624 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • • |
2016-11-16 |
4 |
S |
$16.30 |
$502,529 |
I/I |
(30,830) |
4,036,443 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • • |
2016-11-15 |
4 |
S |
$16.55 |
$511,428 |
I/I |
(30,865) |
4,067,273 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • • |
2016-11-14 |
4 |
S |
$17.16 |
$995,881 |
I/I |
(58,035) |
4,098,138 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • • |
2016-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
4,656,173 |
4,656,173 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
Director |
– • – |
2014-02-10 |
4 |
B |
$12.00 |
$2,793,840 |
I/I |
232,820 |
2,128,678 |
2.1 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
Director |
– • – |
2014-02-10 |
4 |
B |
$12.00 |
$2,793,840 |
I/I |
232,820 |
2,128,678 |
2.1 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
